First coronavirus vaccine trial in the US is recruiting volunteers
Researchers in Seattle have begun recruiting healthy volunteers to participate in a clinical trial for an experimental COVID-19 vaccine, according to news reports.
The vaccine, developed by the biotechnology company Moderna Therapeutics,
was initially sent to the National Institute of Allergy and Infectious Diseases (NIAID) in Maryland on Feb. 24, according to The Wall Street Journal.
The agency
anticipates launching a clinical trial by the end of April and will sponsor the Kaiser Permanente Washington Health Research Institute to conduct the testing, NIAID Director Anthony Fauci told The Wall Street Journal.
Forty-five healthy volunteers
between the ages of 18 and 55
will be enrolled in the initial trial, which aims to determine whether the vaccine triggers an immune response, and whether the given dose causes adverse side effects, according to a description on ClinicalTrials.gov.
Live Science
https://www.livescience.com/us-coronavirus-vaccine-trial-recruiting.html
Moderna
Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus |
Moderna, Inc.